A Comparative Study of the Mammographic Prevalence of Breast Cancer in Nigerian Army Personnel and Civilians Attending 44 Nigerian Army Reference Hospital Kaduna-A Five Years Retrospective Study

Article Sidebar

PDF
Published: Nov 8, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i11-21
Keywords:
Prevalence, Comparative, Mammographic, Breast cancers, Non-Nigerian Army, Nigerian Army personnel

Main Article Content

Jude Nnaemeka Dimkpa
Department of Radiology, 44 Nigerian Army Reference Hospital.
SA Olarinoye-Akorede
Department of Radiology, 44 Nigerian Army Reference Hospital.
H Bello-Sheriff
Department of Public Health, National Open University of Nigeria, Kaduna Study Center.
Vivian Ndidi Akagbue
Department of Radiology, Rivers State University Teaching Hospital. Correspondence Author: Dr Akagbue Vivian Ndidi

Abstract

Background: Breast cancer (BC) is a disease in which abnormal cells in the breast mutate and grow out of control. It is the most common malignancy affecting women in Nigeria. The disease typically affects women of various nationalities and socioeconomic backgrounds, making it a global concern.


Aim: The aim of this study is to determine and compare the prevalence of breast cancer among military personnel and non-military personnel attending the Radiology department of 44 Nigerian Army Reference Hospital Kaduna.


Methods: A retrospective study involving a total of 508 patients who presented for mammography at the radiology department. A P-value below 0.05 was considered statistically significant.


Results: Five-hundred and eight mammographic records were used. The mean age in this study was 44.23years. The prevalence of breast cancer among Nigerian army and civilians in this study were 2.4% and 13.8% respectively. .   


Conclusion: The prevalence of breast cancer is higher among non-Nigerian Army personnel than their Nigerian army counterparts.     

Article Details

How to Cite
Jude Nnaemeka Dimkpa, SA Olarinoye-Akorede, H Bello-Sheriff, & Vivian Ndidi Akagbue. (2023). A Comparative Study of the Mammographic Prevalence of Breast Cancer in Nigerian Army Personnel and Civilians Attending 44 Nigerian Army Reference Hospital Kaduna-A Five Years Retrospective Study. International Journal of Medical Science and Clinical Research Studies, 3(11), 2652–2656. https://doi.org/10.47191/ijmscrs/v3-i11-21
Issue
Vol. 3 No. 11 (2023): Volume 03 Issue 11 November 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Yang X, Wang H, Jiao B. Mammary gland stem cells and their application in breast cancer. Oncotarget. 2017 Feb 2;8(6):10675.

II. Adeloye D, Sowunmi OY, Jacobs W, David RA, Adeosun AA, Amuta AO, Misra S, Gadanya M, Auta A, Harhay MO, Chan KY. Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis. Journal of global health. 2018 Jun;8(1).

III. Sung H., Harper, A., Escandor, N., Heer, E., McCormack, V. and Fidler-Benaoudia, M.M., 2020. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. The Lancet Global Health, 8(8), pp.e1027-e1037.

IV. Soerjomataram I, Ferlay J, Colombet M, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. International journal of cancer. 2021 Aug 15;149(4):778-89.

V. Zhang, Y., Zhou, Y., Mao, F., Yao, R. and Sun, Q., 2020. Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study. Cancer Communications, 40(4), pp.181-193.

VI. Parikh P, Wicher S, Khandalavala K, Pabelick CM, Britt Jr RD, Prakash YS. Cellular senescence in the lung across the age spectrum. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2019 May 1.

VII. Trabert B, Bauer DC, Buist DS, Cauley JA, Falk RT, Geczik AM, Gierach GL, Hada M, Hue TF, Lacey JV, LaCroix AZ. Association of circulating progesterone with breast cancer risk among postmenopausal women. JAMA network open. 2020 Apr 1;3(4):e203645-.

VIII. Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, Kramer BS. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nature Reviews Cancer. 2019 Jun;19(6):349-58.

IX. Shaoyuah Lei, Run Zheng, Siwel Zhang, Shaoming Wing, Ru Chen, Kexin Sin, Hongmei Zing, Jiachin Zhou, Wenquong Wei Global pattern of breast cancer incidence and mortality. A population based cancer registry data analysis from 2000-2020.

X. Kan’an A. Evaluation of breast cancer (BC) awareness among female university students in Zarqa University, Jordan. European journal of breast health. 2018 Oct;14(4):199.

XI. Motilewa BD, Onakoya OA, Oke AO. ICT and gender specific challenges faced by female entrepreneurs in Nigeria. International Journal of Business and Social Science. 2015 Mar 3;6(3):97-105.

XII. Srivastava, K., Jethani, S., Kalthe, B., Khilnani, P.S., Bhawalkar, J.S. and Vyas, S., 2016. Awareness of breast cancer risk factors and practice of breast self-examination among nurses of tertiary care hospital. Ind J For Comm Med, 3, pp.75-78.

XIII. Obaji, N.C., Elom, H.A., Agwu, U.M., Nwigwe, C.G., Ezeonu, P.O. and Umeora, O.U.J., 2013. Awareness and practice of breast self. Examination among market women in Abakaliki, South East Nigeria. Annals of medical and health sciences research, 3(1), pp.7-12.

XIV. Ahmed A, Ukwenya Y, Abdullahi A, Muhammad I. Management and outcomes of male breast cancer in Zaria, Nigeria. International journal of breast cancer. 2012 Jan 1;2012.

XV. Umana, U.E., Ahunna, C.O., Timbuak, J.A., Ibegbu, A.O., Musa, S.A. and Hamman, W.O., 2013. Dermatoglyphics and cheiloscopic patterns in cancer patients; A study in Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria. Current research journal of biology sciences, 5(5), p.220.

XVI. https://www.vanguardngr.com 8 Feb 2020

XVII. Barbie DA, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, Zhong J, Rangachari D, Farago AF, Phat S, Myers DT. Combination olaparib and temozolomide in relapsed small-cell lung cancer. Cancer discovery. 2019 Oct 1;9(10):1372-87.

XVIII. Mohammed I, Mohammed A. Assessment Of Modern Contraceptive Utilization Coverage In Niger State. Assessment. 2023 Jun;28(9).

XIX. See BH, Morris R, Gorard S, El Soufi N. What works in attracting and retaining teachers in challenging schools and areas?. Oxford Review of Education. 2020 Nov 1;46(6):678-97.

XX. Malik SS, Iqra, Akhtar N, Fatima I, Akram Z, Masood N. Molecular profiling of breast cancer in clinical trials: a perspective. 'Essentials of cancer genomic, computational approaches and precision medicine. 2020:313-32.

XXI. Gbadamosi IT, Erinoso SM. A review of twenty ethnobotanicals used in the management of breast cancer in Abeokuta, Ogun State, Nigeria. African Journal of Pharmacy and Pharmacology. 2016 Jul 22;10(27):546-64.

XXII. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. International journal of cancer. 2021 Aug 15;149(4):778-89.

XXIII. Enewold L, Zhou J, McGlynn KA, Anderson WF, Shriver CD, Potter JF, Zahm SH, Zhu K. Racial variation in breast cancer treatment among Department of Defense beneficiaries. Cancer. 2012 Feb 1;118(3):812-20.

XXIV. Katuwal S, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Weiderpass E, Pukkala E. Occupational variation in the risk of female breast cancer in the Nordic countries. Cancer Causes & Control. 2018 Nov;29:1027-38.

XXV. Nggada HA, Yawe KD, Abdulazeez J, Khalil MA. Breast cancer burden in Maiduguri, North eastern Nigeria. The breast journal. 2008 May;14(3):284-6.

XXVI. Olaogun, J.G., Omotayo, J.A., Ige, J.T., Omonisi, A.E., Akute, O.O. and Aduayi, O.S., 2020. Socio-demographic, pattern of presentation and management outcome of breast cancer in a semi-urban tertiary health institution. Pan African Medical Journal, 36(1).

XXVII. Elenwo SN, Ijah RF, Okoh PD. Pattern of Presentation and Problems of Breast Cancer in Port Harcourt, Nigeria. Int J Contemp Med Surg Radiol. 2021;6(4):D13-8.